Schwazze Q3 2023 Touts $46.7M Revenue Thanks To Expanding Retail Footprint: 63 Weed Shops And Counting

Medicine Man Technologies Inc., operating as Schwazze SHWZ SHWZ, disclosed its financial and operational results for the third quarter ending September 30, 2023.

CEO Nirup Krishnamurthy highlighted the company's expanded retail footprint of 63 stores in Colorado and New Mexico, along with advancements in wholesale operations.

See Also: Schwazze Acquires Smokey's Dispensaries In $7.5M Deal, Expanding Colorado Presence

Key Financial Highlights

  • Total Revenue: In Q3 2023, total revenue increased by 8% to $46.7 million, compared to $43.2 million in the same period last year. The growth was attributed to new store expansion and increased wholesale revenue, partially offset by pricing pressures in New Mexico.
  • Gross Profit: Gross profit for Q3 2023 was $21.4 million or 45.9% of total revenue, reflecting a decrease from the same quarter last year. This was primarily driven by a true-up expense reclassification and lower initial gross margin from the Everest Apothecary's inventory acquisition.
  • Operating Expenses: Operating expenses for Q3 2023 were $12.5 million, up from $11.4 million in the same period last year. The increase was associated with SG&A increases related to new stores in Colorado and New Mexico.
  • Income from Operations: Income from operations was $8.9 million for Q3 2023, compared to $11.1 million in the same quarter last year.
  • Net Loss: The net loss for Q3 2023 was $0.3 million, in contrast to a net income of $1.8 million in Q3 2022.
  • Adjusted EBITDA: Adjusted EBITDA for Q3 2023 was $14.1 million or 30.2% of revenue, compared to $15.9 million or 36.7% of revenue for the same quarter last year. The decrease in margin was driven by lower gross margin and higher SG&A associated with new stores.

Financial Position

  • Cash and Cash Equivalents: $19.6 million, down from $38.9 million on December 31, 2022.
  • Operating Working Capital: Decreased by $3.5 million to $0.6 million.
  • Total Debt: $155.1 million, compared to $127.8 million on December 31, 2022.

Schwazze CFO Forrest Hoffmaster emphasized the company's strategic focus on revenue growth, customer acquisition, and positive cash flow. “We are also making steady progress on integrating our recent acquisitions to drive operational efficiencies and cost synergies at scale." 

Price Action

SHWZ's shares were trading 9.07% higher at $0.60 per share on Tuesday afternoon.

Read Next: Mary Jones Cannabis Sodas' Revenue Drop, Q3 Was 'More Challenging Than Expected,' CEO Says

Image by El Planteo

Market News and Data brought to you by Benzinga APIs
Date
ticker
name
Actual EPS
EPS Surprise
Actual Rev
Rev Surprise
Posted In: CannabisEarningsNewsPenny StocksMarketsForrest HoffmasterMedicine Man Technologies Inc.Nirup KrishnamurthySchwazze
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

The Benzinga Cannabis Capital Conference is coming to Florida

The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.

Get your tickets now on bzcannabis.com – Prices will increase very soon!


Loading...